Back to Newsroom
Back to Newsroom

Five Star Equities Issues New Research Reports on CALX, CPST, MG and MNKD

Friday, 10 January 2014 08:50 AM

Topic:

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Calix Inc. (NYSE: CALX) shares declined 10.28 percent to close at $8.29 a share Thursday. The stock traded between $8.24 and $8.91 on volume 1.58 million shares traded. The company announced that it expects revenue and non-GAAP earnings per share for the fourth quarter of 2013 to be below previous guidance. Shares of Calix have gained approximately 8.0 percent in the past year.

Get more information on Calix free access to the in-depth equity report at:  
www.FiveStarEquities.com/CALX

Capstone Turbine Corporation (NASDAQ: CPST) shares surged 8.28 percent to close at $1.57 a share Thursday. The stock traded between $1.49 and $1.69 on volume 20.24 million shares traded. The company announced that it received multiple orders from E-Finity Distributed Generation totaled 6.4MW. Shares of Capstone Turbine have gained approximately 70.0 percent in the past year.

Get more information on Capstone Turbine and free access to the in-depth equity report at:  
www.FiveStarEquities.com/CPST

Mistras Group Inc. (NYSE: MG) shares gained 7.98 percent to close at $24.23 a share Thursday. The stock traded between $23.08 and $24.60 on volume of 562,527 shares traded. The company reported revenues of $156.8 million for the second quarter of fiscal 2014, an increase of 13.8 percent when compared to a year ago. Shares of Mistras Group have gained approximately 15.0 percent in the past year.

Get more information on Mistras Group and free access to the in-depth equity report at:  
www.FiveStarEquities.com/MG

MannKind Corporation (NASDAQ: MNKD) shares spiked 18.39 percent to close at $7.08 a share Thursday. The stock traded between $6.02 and $7.21 on volume 24.87 million shares traded. The company is scheduled to present at the J.P. Morgan 2014 Healthcare Conference on Wednesday, January 15, 2014. Shares of MannKind have gained approximately 180.0 percent in the past year.

Get more information on MannKind and free access to the in-depth equity report at:  
www.FiveStarEquities.com/MNKD

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:          
Five Star Equities
[email protected]

Topic:
Back to newsroom
Back to Newsroom
Share by: